ESPN 51th Annual Meeting

ESPN 2018


 
DO MORTALITY DIFFERENCES BETWEEN ROMA AND NON-ROMA CHILDREN ON RENAL REPLACEMENT THERAPY EXIST?
Gabriel Kolvek 1 Eva Sadova 1 Martin Dluholucky 2 Magdalena Antonyova 3 Ludmila Podracka 4

1- Department of paediatrics, Safarik University, Kosice, Slovakia
2- Department of paediatrics, Banska Bystrica, Slovakia
3- Department of paediatrics, Jesenius faculty of medicine of Commenius University, Martin, Slovakia
4- Department of paediatrics, Commenius University, Bratislava, Slovakia
 
Introduction:

To evaluate potential differences in mortality between Roma and Non-Roma children on renal replacement therapy (RRT). 

Material and methods:

Data on 117 RRT children (0-18years; 1991-2017; 62.4% boys) from whole Slovakia (population of 5.42 million, about 1 million children) were available for analysis. Survival on RRT was tested using the Kaplan-Meier survival analysis and compared by ethnicity using a log rank test.

Results:

The mean age at RRT initiation was 11.3 years and the mean time of follow-up was 5.5 years (SD 4.0 years). The most common etiology of ESRD was congenital anomalies (38.0%) followed by hereditary cystic diseases (19.1%). Overall 5-year survival during the study period was 91.9%. The most frequent cause of death was infection (5 cases) followed by cardiovascular causes (3 cases). Roma represented 20.5% of RRT patients (Non-Roma 82, Roma 24, unknown 11). Survival of Roma children did not differ significantly from their Non-Roma peers (p=0.51). Five-year survival of Roma and Non-Roma was 94.4% and 91.2% respectively.

Conclusions:

Mortality of Roma RRT children in Slovakia does not seem to differ significantly from the mortality of their Non-Roma peers. Limited size of the sample did not allow mortality adjustment for etiologies and treatment modalities. Further studies are necessary to analyse potential differences in survival of RRT children on the ethnic grounds.